$2.5 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 99 reported holdings in Q4 2018. The portfolio turnover from Q3 2018 to Q4 2018 was 60.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Buy | HORIZON PHARMA PLC | $133,375,000 | +3.1% | 6,825,719 | +3.3% | 5.34% | +15.2% |
| ORTX | New | ORCHARD THERAPEUTICS PLCads | $126,211,000 | – | 8,023,600 | +100.0% | 5.05% | – |
| Buy | HORIZON PHARMA INVT LTDnote 2.500% 3/1 | $112,678,000 | +13.2% | 113,532,000 | +14.6% | 4.51% | +26.5% | |
| MYL | Buy | MYLAN N V | $77,645,000 | +15.2% | 2,833,741 | +53.8% | 3.11% | +28.7% |
| VCEL | Buy | VERICEL CORP | $64,831,000 | +183.2% | 3,725,900 | +130.3% | 2.60% | +216.5% |
| XLRN | Buy | ACCELERON PHARMA INC | $60,384,000 | -5.6% | 1,386,541 | +24.1% | 2.42% | +5.5% |
| Buy | INTERCEPT PHARMACEUTICALS INnote 3.250% 7/0 | $53,020,000 | +46.3% | 57,791,000 | +60.5% | 2.12% | +63.5% | |
| MYOK | Buy | MYOKARDIA INC | $48,713,000 | -18.5% | 997,000 | +8.7% | 1.95% | -9.0% |
| ANAB | Buy | ANAPTYSBIO INC | $47,424,000 | -26.6% | 743,439 | +14.8% | 1.90% | -18.0% |
| ACRS | Buy | ACLARIS THERAPEUTICS INC | $43,552,000 | -3.0% | 5,893,416 | +90.5% | 1.74% | +8.3% |
| UHS | Buy | UNIVERSAL HLTH SVCS INCcl b | $38,698,000 | +15.5% | 332,000 | +26.7% | 1.55% | +29.1% |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $37,301,000 | -22.0% | 341,800 | +15.5% | 1.49% | -12.8% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $37,096,000 | -6.3% | 874,486 | +4.0% | 1.48% | +4.7% |
| NVRO | Buy | NEVRO CORP | $35,556,000 | +18.8% | 914,273 | +74.1% | 1.42% | +32.7% |
| CNC | Buy | CENTENE CORP DEL | $32,976,000 | -7.0% | 286,000 | +16.7% | 1.32% | +3.9% |
| KNSA | Buy | KINIKSA PHARMACEUTICALS LTD | $31,709,000 | +17.1% | 1,128,822 | +6.3% | 1.27% | +30.8% |
| ASND | Buy | ASCENDIS PHARMA A Ssponsored adr | $31,644,000 | +39.6% | 505,098 | +57.8% | 1.27% | +56.0% |
| DPLO | Buy | DIPLOMAT PHARMACY INC | $31,617,000 | +90.8% | 2,348,993 | +175.2% | 1.27% | +113.1% |
| RARX | Buy | RA PHARMACEUTICALS INC | $27,336,000 | +294.9% | 1,502,000 | +292.5% | 1.09% | +341.1% |
| GLPG | Buy | GALAPAGOS NVspon adr | $26,458,000 | -9.5% | 288,407 | +10.9% | 1.06% | +1.1% |
| IMMU | Buy | IMMUNOMEDICS INC | $26,160,000 | -21.0% | 1,833,202 | +15.3% | 1.05% | -11.7% |
| AGN | New | ALLERGAN PLC | $24,059,000 | – | 180,000 | +100.0% | 0.96% | – |
| FATE | Buy | FATE THERAPEUTICS INC | $21,232,000 | +11.1% | 1,654,865 | +41.0% | 0.85% | +24.1% |
| TNDM | Buy | TANDEM DIABETES CARE INC | $21,026,000 | +73.4% | 553,765 | +95.6% | 0.84% | +94.0% |
| RETA | Buy | REATA PHARMACEUTICALS INCcl a | $20,420,000 | -15.0% | 364,000 | +23.8% | 0.82% | -5.1% |
| SIEN | Buy | SIENTRA INC | $19,991,000 | +41.0% | 1,572,891 | +164.9% | 0.80% | +57.5% |
| MOH | New | MOLINA HEALTHCARE INC | $17,639,000 | – | 151,772 | +100.0% | 0.71% | – |
| NTRA | New | NATERA INC | $17,492,000 | – | 1,253,000 | +100.0% | 0.70% | – |
| INSP | Buy | INSPIRE MED SYS INC | $16,933,000 | +112.9% | 400,781 | +112.1% | 0.68% | +137.9% |
| New | EXACT SCIENCES CORPdbcv 1.000% 1/1 | $16,499,000 | – | 15,000,000 | +100.0% | 0.66% | – | |
| ADUS | Buy | ADDUS HOMECARE CORP | $15,809,000 | +243.6% | 232,900 | +255.1% | 0.63% | +283.6% |
| DCPH | New | DECIPHERA PHARMACEUTICALS IN | $12,754,000 | – | 607,633 | +100.0% | 0.51% | – |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $10,627,000 | +110.4% | 109,117 | +273.1% | 0.42% | +134.8% |
| AXGT | New | AXOVANT SCIENCES LTD | $9,960,000 | – | 10,000,000 | +100.0% | 0.40% | – |
| OSMT | New | OSMOTICA PHARMACEUTICALS PLC | $8,821,000 | – | 1,138,256 | +100.0% | 0.35% | – |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $8,801,000 | – | 326,797 | +100.0% | 0.35% | – |
| EXAS | New | EXACT SCIENCES CORP | $8,140,000 | – | 129,000 | +100.0% | 0.33% | – |
| ATNX | New | ATHENEX INC | $7,750,000 | – | 610,700 | +100.0% | 0.31% | – |
| STIM | New | NEURONETICS INC | $3,077,000 | – | 159,000 | +100.0% | 0.12% | – |
| AACH | Buy | AAC HLDGS INC | $2,710,000 | -80.8% | 1,936,027 | +4.4% | 0.11% | -78.7% |
| MGTX | New | MEIRAGTX HOLDINGS PLC | $2,256,000 | – | 234,000 | +100.0% | 0.09% | – |
| AXGN | New | AXOGEN INC | $2,138,000 | – | 104,674 | +100.0% | 0.09% | – |
| NEOS | New | NEOS THERAPEUTICS INC | $2,030,000 | – | 1,230,267 | +100.0% | 0.08% | – |
| PTI | New | PROTEOSTASIS THERAPEUTICS IN | $1,358,000 | – | 419,000 | +100.0% | 0.05% | – |
| MNKD | New | MANNKIND CORP | $1,000,000 | – | 943,298 | +100.0% | 0.04% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-02-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-06-14 |
| 4 | 2024-06-03 |
| 13F-HR | 2024-05-15 |
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.